Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,633 | -141,372 | -184,678 | -143,045 | -98,882 |
| Depreciation Amortization | 795 | 405 | 1,758 | 1,341 | 899 |
| Accounts receivable | -2,731 | 172 | -8,643 | -8,317 | -7,607 |
| Accounts payable and accrued liabilities | -769 | -1,251 | 14,773 | 9,915 | 5,828 |
| Other Working Capital | -4,334 | -2,188 | 4,807 | -4,102 | -2,524 |
| Other Operating Activity | 110,853 | 103,491 | 35,826 | 37,434 | 24,763 |
| Operating Cash Flow | $-69,819 | $-40,743 | $-136,157 | $-106,774 | $-77,523 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 61,488 | 70,050 | 49 | -22,590 | 72,097 |
| PPE Investments | -40,000 | -40,000 | -5,714 | -5,715 | -5,442 |
| Investing Cash Flow | $21,488 | $30,050 | $-5,665 | $-28,305 | $66,655 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 24,370 | 24,370 | N/A |
| Debt Repayment | -5,756 | -2,783 | -7,398 | -4,824 | -2,657 |
| Common Stock Issued | 8,428 | 7,026 | 57,396 | 52,399 | 1,559 |
| Other Financing Activity | 147,750 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $150,422 | $4,243 | $74,368 | $71,945 | $-1,098 |
| Exchange Rate Effect | -372 | -71 | -142 | 50 | -27 |
| Beginning Cash Position | 60,409 | 60,409 | 128,005 | 128,005 | 128,005 |
| End Cash Position | 162,128 | 53,888 | 60,409 | 64,921 | 116,012 |
| Net Cash Flow | $101,719 | $-6,521 | $-67,596 | $-63,084 | $-11,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,819 | -40,743 | -136,157 | -106,774 | -77,523 |
| Capital Expenditure | -40,000 | -40,000 | -5,714 | -5,715 | -5,442 |
| Free Cash Flow | -109,819 | -80,743 | -141,871 | -112,489 | -82,965 |